Back to search
FDAFDA · Food and drugs·Recall number D-1172-2023

Cequa (cyclosporine ophthalmic solution) 0.09%, 60 Single-Use Vials (6 pouches x 10 single-use vials (0.25 mL each)), Rx only, Manufactured for Sun Pharma Global FZE by: Laboratoire Unither, Coutances, France NDC 47335-506-96

Published September 27, 2023 · Recall initiated: September 7, 2023

Summary

FDA records drug Class III recall D-1172-2023, published September 27, 2023 and initiated September 7, 2023. Recalling firm: SUN PHARMACEUTICAL INDUSTRIES INC; Status: Terminated; Reported quantity: 69,707 cartons; Lot: Lot# 10026, Lot 10027, Exp. 09/2023. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Subpotent: Out of Specification result observed for low assay

What to do

Voluntary: Firm initiated · Letter

Get an email if CEQUA has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
CEQUA
Manufacturer
SUN PHARMACEUTICAL INDUSTRIES INC
Distributor
Nationwide wide in the USA
Lot
Lot# 10026, Lot 10027, Exp. 09/2023.
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Cequa (cyclosporine ophthalmic solution) 0.09%, 60 Single-Use Vials (6 pouches x 10 single-use vials (0.25 mL each)), Rx only, Manufactured for Sun Pharma Global FZE by: Laboratoire Unither, Coutances, France NDC 47335-506-96 recalled?

Yes. FDA published recall D-1172-2023 on September 27, 2023. Reported hazard: Subpotent: Out of Specification result observed for low assay

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: CEQUA.